20/10/2026
A herb found in dozens of complementary cold and flu supplements will no longer be classified as a low-risk ingredient over links to anaphylaxis, including one reported death.
Products containing Andrographis paniculata will not be included on the Australian Register of Therapeutic Goods as listed medicines.